Other Species / Isoforms
  PKN3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K20-ub
QWPPEDEkEVIRRAI
0 1
PKN3 (human) QWPPEDEkEVIRRAI K20-ub
PKN3 (mouse) QRAPKDEKEMVRRAI K17
K29-ub
VIRRAIQkELKIKEG
0 1
PKN3 (human) VIRRAIQkELKIKEG K29-ub
PKN3 (mouse) MVRRAIQKELKIKEG K26
T45-p
ENLRRVAtDRRHLGH
0 1
PKN3 (human) ENLRRVAtDRRHLGH T45-p
PKN3 (mouse) ENMRRVATDRRHLGH T42
R58-m1
GHVQQLLrSSNRRLE
0 1
PKN3 (human) GHVQQLLrSSNRRLE R58-m1
PKN3 (mouse) GHVQQLLRASNRRLE R55
T135-p
THTCASGtPKERkLL
0 1
PKN3 (human) THTCASGtPKERkLL T135-p
PKN3 (mouse) IHTCASGTPKERKLL T128
K140-ub
SGtPKERkLLAAAQQ
0 1
PKN3 (human) SGtPKERkLLAAAQQ K140-ub
PKN3 (mouse) SGTPKERKLLAAAQQ K133
K155-ub
MLRDSQLkVALLRMK
0 1
PKN3 (human) MLRDSQLkVALLRMK K155-ub
PKN3 (mouse) MLKDSQLKVALLRMK K148
S171-p
SSLEASGsPEPGPEL
0 1
PKN3 (human) SSLEASGsPEPGPEL S171-p
PKN3 (mouse) SSLESSGSPEPGPDL S164
K198-ub
AAVAEGAkNVVkLLS
0 1
PKN3 (human) AAVAEGAkNVVkLLS K198-ub
PKN3 (mouse) AAVAAGAKNVVKLLG K191
K202-ub
EGAkNVVkLLSSRRT
0 1
PKN3 (human) EGAkNVVkLLSSRRT K202-ub
PKN3 (mouse) AGAKNVVKLLGGQRM K195
K213-ub
SRRTQDRkALAEAQA
0 1
PKN3 (human) SRRTQDRkALAEAQA K213-ub
PKN3 (mouse) GQRMQDRKALAEAQA K206
K273-ub
QPSGTPVkPTALTGT
0 1
PKN3 (human) QPSGTPVkPTALTGT K273-ub
PKN3 (mouse) QPLGTLVKPIALTGT K266
S299-p
LTAVPGRsPAAALAS
0 1
PKN3 (human) LTAVPGRsPAAALAS S299-p
PKN3 (mouse) LVAVPGRSPMAVLAG S292
S307-p
PAAALASsPSEGWLR
Upstream
0 3
Treatment
  • MG132_withdrawal
PKN3 (human) PAAALASsPSEGWLR S307-p
PKN3 (mouse) PMAVLAGSPSESWLR S300
S466-p
MNLLPPCsSPSTIsP
Upstream
0 1
Treatment
  • BI2536
PKN3 (human) MNLLPPCsSPSTIsP S466-p
PKN3 (mouse) MSLLPPCSSPNTASP S459
S472-p
CsSPSTIsPPKGCPR
Upstream
0 1
Treatment
  • BI2536
PKN3 (human) CsSPSTIsPPKGCPR S472-p
PKN3 (mouse) CSSPNTASPPKGRPS S465
T480-p
PPKGCPRtPTTLREA
0 3
PKN3 (human) PPKGCPRtPTTLREA T480-p
PKN3 (mouse) PPKGRPSTAVCGTPS T473
S488-p
PTTLREAsDPAtPsN
0 2
PKN3 (human) PTTLREAsDPAtPsN S488-p
PKN3 (mouse) AVCGTPSAASPSNFL A481
T492-p
REAsDPAtPsNFLPk
0 6
PKN3 (human) REAsDPAtPsNFLPk T492-p
PKN3 (mouse) CGTPSAASPSNFLPM S483
S494-p
AsDPAtPsNFLPkKT
Upstream
0 1
Treatment
  • MG132_withdrawal
PKN3 (human) AsDPAtPsNFLPkKT S494-p
PKN3 (mouse) TPSAASPSNFLPMkT S485
K499-ub
tPsNFLPkKTPLGEE
0 1
PKN3 (human) tPsNFLPkKTPLGEE K499-ub
PKN3 (mouse) SPSNFLPMkTLSKED M490
K500
PsNFLPkKTPLGEEM
0 1
PKN3 (human) PsNFLPkKTPLGEEM K500
PKN3 (mouse) PSNFLPMkTLSKEDT K491-ac
T508-p
TPLGEEMtPPPkPPR
0 3
PKN3 (human) TPLGEEMtPPPkPPR T508-p
PKN3 (mouse) TLSKEDTKPPPKPPR K499
K512-ub
EEMtPPPkPPRLYLP
0 1
PKN3 (human) EEMtPPPkPPRLYLP K512-ub
PKN3 (mouse) EDTKPPPKPPRLYLQ K503
T523-p
LYLPQEPtsEEtPRT
Upstream
0 1
Treatment
  • MG132_withdrawal
PKN3 (human) LYLPQEPtsEEtPRT T523-p
PKN3 (mouse) gap -
S524-p
YLPQEPtsEEtPRTK
0 1
PKN3 (human) YLPQEPtsEEtPRTK S524-p
PKN3 (mouse) RLYLQEPAPGTPCTK A513
T527-p
QEPtsEEtPRTKRPH
0 5
PKN3 (human) QEPtsEEtPRTKRPH T527-p
PKN3 (mouse) LQEPAPGTPCTKRPH T516
S544-p
PRTRRGPsPPAsPtR
Upstream
0 16
Treatment
  • nocodazole
  • thymidine
PKN3 (human) PRTRRGPsPPAsPtR S544-p
PKN3 (mouse) PRPAVVPALAALSTR A533
S548-p
RGPsPPAsPtRKPPR
0 12
PKN3 (human) RGPsPPAsPtRKPPR S548-p
PKN3 (mouse) VVPALAALSTRKPPR L537
T550-p
PsPPAsPtRKPPRLQ
0 2
PKN3 (human) PsPPAsPtRKPPRLQ T550-p
PKN3 (mouse) PALAALSTRKPPRLQ T539
K583-ac
VQFKGTGkYYAIkAL
0 1
PKN3 (human) VQFKGTGkYYAIkAL K583-ac
PKN3 (mouse) VQYKGTGKYYAIKAL K572
K583-ub
VQFKGTGkYYAIkAL
0 1
PKN3 (human) VQFKGTGkYYAIkAL K583-ub
PKN3 (mouse) VQYKGTGKYYAIKAL K572
K588-ub
TGkYYAIkALKkQEV
0 1
PKN3 (human) TGkYYAIkALKkQEV K588-ub
PKN3 (mouse) TGKYYAIKALKKQEV K577
K592-ub
YAIkALKkQEVLSRD
0 2
PKN3 (human) YAIkALKkQEVLSRD K592-ub
PKN3 (mouse) YAIKALKKQEVLGRD K581
A613
CEKRILEAVGCTGHP
0 1
PKN3 (human) CEKRILEAVGCTGHP A613
PKN3 (mouse) CEKRILEtVGRTGHP T602-p
K686-ub
KIIYRDLkLDNLLLD
0 3
PKN3 (human) KIIYRDLkLDNLLLD K686-ub
PKN3 (mouse) RIIYRDLKLDNLLLD K675
T716-p
GIGFGDRtstFCGtP
0 13
PKN3 (human) GIGFGDRtstFCGtP T716-p
PKN3 (mouse) GIGFGDRTStFCGTP T705
S717-p
IGFGDRtstFCGtPE
0 39
PKN3 (human) IGFGDRtstFCGtPE S717-p
PKN3 (mouse) IGFGDRTStFCGTPE S706
T718-p
GFGDRtstFCGtPEF
Upstream
Downstream
2 65
Effects on Modified Protein
  • enzymatic activity, induced
Treatment
  • 4-HT
  • insulin
  • LY294002
  • rapamycin
  • U0126
  • U46619
PKN3 (human) GFGDRtstFCGtPEF T718-p
PKN3 (mouse) GFGDRTStFCGTPEF T707-p
T722-p
RtstFCGtPEFLAPE
0 4
PKN3 (human) RtstFCGtPEFLAPE T722-p
PKN3 (mouse) RTStFCGTPEFLAPE T711
K796-ub
FIQKLLQkCPEKRLG
0 1
PKN3 (human) FIQKLLQkCPEKRLG K796-ub
PKN3 (mouse) LIQKLLQKSPEKRLG K785
K813-ub
EQDAEEIkVQPFFRt
0 1
PKN3 (human) EQDAEEIkVQPFFRt K813-ub
PKN3 (mouse) ERDAEEIKVQPFFRT K802
T820-p
kVQPFFRtTNWQALL
0 1
PKN3 (human) kVQPFFRtTNWQALL T820-p
PKN3 (mouse) KVQPFFRTTNWQALL T809
T860-p
TGLPPALtPPAPHSL
0 8
PKN3 (human) TGLPPALtPPAPHSL T860-p
PKN3 (mouse) TSLPPTLTPPVSQSS T849